The DOI matches its Crossref record.
Cyclophilin D as a Drug Target
Abstract
The mitochondrial permeability transition (MPT) plays an important role in damage-induced cell death, and agents inhibiting the MPT may have a therapeutic potential for treating human conditions such as ischemia/reperfusion injury, trauma, and neurodegenerative diseases. The mitochondrial matrix protein, cyclophilin D (CYP D), a member of a family of highly homologous peptidylprolyl cis-trans isomerases (PPIases), plays a decisive role in MPT, being an integral constituent of the MPT pore. Other putative MPT pore proteins include the adenine nucleotide translocator (ANT) and the voltage-dependent anion channel (VDAC). In an alternative model, the MPT pore is formed by clusters of misfolded membrane proteins outlining aqueous channels that are regulated by CYP D and other chaperone-like proteins. Like cyclophilin A (CYP A) and other cyclophilin family members, CYP D is targeted by the immunosuppressant cyclosporin A (CsA). CsA is cytoprotective in many cellular and animal models, but protection may result from either inhibition of the MPT through an interaction with CYP D or inhibition of calcineurin-mediated dephosphorylation of BAD through an interaction with CYP A. The relevance of MPT inhibition by CsA for its cytoprotective effects is well documented in many cellular models. Mechanisms of action in vivo are more difficult to define, and accordingly the evidence is as yet less compelling in in vivo animal models of ischemia/reperfusion injury, trauma and neurodegenerative diseases. Notwithstanding, CYP D is a drug target of high interest. Structural considerations suggest feasibility of designing CYP D ligands without immunosuppressant properties. This is highly desirable, since they have the potential of being useful therapeutic agents in a variety of disease states. It might be a tougher challenge to obtain compounds specific for CYP D vs. other cyclophilins, and/or of small molecular weight, allowing brain penetration to make them suitable for treating neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Selective degradation of mitochondria by mitophagy
Kim, I., Rodriguez-Enriquez, S., & Lemasters, J. J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.034 · Cited by 1,558
Self-citationMOLECULAR AND EVOLUTIONARY BASIS OF THE CELLULAR STRESS RESPONSE
Kültz, D. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.103635 · Cited by 1,511
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759
Apoptosis and Necrosis in the Liver: A Tale of Two Deaths?
Malhi, H., Gores, G. J., & Lemasters, J. J. (2006) · Hepatology · doi:10.1002/hep.21062 · Cited by 691
Self-citationMitochondrial calcium and the permeability transition in cell death
Lemasters, J. J., Theruvath, T. P., Zhong, Z., & Nieminen, A.-L. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.06.009 · Cited by 654
Self-citationOxidants, antioxidants and the ischemic brain
Warner, D. S., Sheng, H., & Batinić-Haberle, I. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01022 · Cited by 598
Hafner, A. V., Dai, J., Gomes, A. P., Xiao, C.-Y., Palmeira, C. M., Rosenzweig, A., & Sinclair, D. A. (2010) · Aging · doi:10.18632/aging.100252 · Cited by 545
Kon, K., Kim, J.-S., Jaeschke, H., & Lemasters, J. J. (2004) · Hepatology · doi:10.1002/hep.20437 · Cited by 494
Self-citationCyclophilin B Is a Functional Regulator of Hepatitis C Virus RNA Polymerase
Watashi, K., Ishii, N., Hijikata, M., Inoue, D., Murata, T., Miyanari, Y., & Shimotohno, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.014 · Cited by 454
Astrocyte apoptosis: implications for neuroprotection
Takuma, K., Baba, A., & Matsuda, T. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.001 · Cited by 435
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
The role of mitochondria in protection of the heart by preconditioning
Halestrap, A. P., Clarke, S. J., & Khaliulin, I. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.05.008 · Cited by 390
Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death?
Sullivan, P. G., Rabchevsky, A. G., Waldmeier, P. C., & Springer, J. E. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20292 · Cited by 383
Self-citationTracker Dyes to Probe Mitochondrial Autophagy (Mitophagy) in Rat Hepatocytes
Rodriguez-Enriquez, S., Kim, I., Currin, R. T., & Lemasters, J. J. (2006) · Autophagy · doi:10.4161/auto.2229 · Cited by 330
Self-citationKim, J.-S., Jin, Y., & Lemasters, J. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00683.2005 · Cited by 310
Self-citationMitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
Szeto, H. H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 274
Geisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104
“Some diseases in particular, such as epilepsy, DMD, TBI, and those associated with misfolded proteins (PD, AD, HD, etc.) are associated with ER stress and Ca2+ overload.”
BackgroundInfluentialHou, Y., Mattson, M. P., & Cheng, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076721 · Cited by 39
“A protein that is associated with mPTP is cyclophilin D, which is a molecular target of cycosporin A, a drug that inhibits mPTP opening [13].”
Treatment strategies for Leber hereditary optic neuropathy
Jurkute, N., Harvey, J., & Yu-Wai-Man, P. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000646 · Cited by 38
“Cyclosporine A blocks apoptosis by inhibiting mitochondrial permeability transition and its therapeutic potential in LHON has been evaluated in 5 patients with subacute, unilateral LHON, who had been diagnosed within 6 months of disease onset [21,22].”
BackgroundShen, Y., Yu, Y., Chaurasiya, B., Li, X., Xu, Y., Webster, T., Tu, J., & Sun, R. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s173691 · Cited by 35
Metadata
- Authors
- Waldmeier, P., Zimmermann, K., Qian, T., Tintelnot-Blomley, M., & Lemasters, J.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-08-01
- Volume
- 10
- Issue
- 16
- Pages
- 1485-1506
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2146733063
- Cited by
- 234
- References
- 0
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.